NCT00117611View on ClinicalTrials.gov

Xolair in Patients With Chronic Sinusitis

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

January 31, 2009

Conditions
Sinusitis
Interventions
DRUG

Anti-IgE antibody omalizumab or placebo

given subcutaneously oce or twice monthly depending on dose

Trial Locations (1)

60637

The University of Chicago, Chicago

Sponsors
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of Chicago

OTHER